Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Crossover Comparative Bioavailability Study of Febuxostat 120 mg Film-Coated Tablets in Healthy Adult Subjects / Fasting State

NCT03918551 is registered in ClinicalTrials.gov with Pharmtechnology LLC as lead sponsor.

NCT NCT03918551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Crossover Comparative Bioavailability Study of Febuxostat 120 mg Film-Coated Tablets in Healthy Adult Subjects / Fasting State
Lead sponsor
Pharmtechnology LLC
Phase
Phase 1
Overall status
Completed
Start date
May 3, 2019
Completion date
June 6, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence